GLP-1受体激动剂-话题@MedSci

#GLP-1受体激动剂#

37篇内容 | 2894人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1294020, encodeId=bf17129402072, content=<a href='/topic/show?id=bb0e8081b2' target=_blank style='color:#2F92EE;'>#GLP-1受体激动剂#</a>, objectTitle=Diabetes Care：GLP-1受体激动剂可以作为青少年的成年发病型糖尿病(MODY)3型的替代治疗, objectType=article, longId=36769, objectId=f77936e69cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f77936e69cd, replyNumber=0, likeNumber=89, createdTime=2014-06-21, rootId=0, userName=Eleven11, userId=e183245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f77936e69cd, moduleTitle=Diabetes Care：GLP-1受体激动剂可以作为青少年的成年发病型糖尿病(MODY)3型的替代治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f77936e69cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294019, encodeId=617312940194f, content=<a href='/topic/show?id=bb0e8081b2' target=_blank style='color:#2F92EE;'>#GLP-1受体激动剂#</a>, objectTitle=Sanofi推迟GLP-1受体激动剂lixisenatide在FDA的申请, objectType=article, longId=24431, objectId=a5022443132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5022443132, replyNumber=0, likeNumber=102, createdTime=2013-09-15, rootId=0, userName=Eleven11, userId=e183245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5022443132, moduleTitle=Sanofi推迟GLP-1受体激动剂lixisenatide在FDA的申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5022443132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294018, encodeId=cc921294018bd, content=<a href='/topic/show?id=bb0e8081b2' target=_blank style='color:#2F92EE;'>#GLP-1受体激动剂#</a>, objectTitle=PUDF 2013：母义明-GLP-1受体激动剂，它们都一样吗？, objectType=article, longId=19468, objectId=1004194680a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1004194680a, replyNumber=0, likeNumber=78, createdTime=2013-06-01, rootId=0, userName=Eleven11, userId=e183245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1004194680a, moduleTitle=PUDF 2013：母义明-GLP-1受体激动剂，它们都一样吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1004194680a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294017, encodeId=577e129401e6f, content=<a href='/topic/show?id=bb0e8081b2' target=_blank style='color:#2F92EE;'>#GLP-1受体激动剂#</a>, objectTitle=JAMA Pediatr:GLP-1受体激动剂抗青少年重度肥胖, objectType=article, longId=15216, objectId=a583152166d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a583152166d, replyNumber=0, likeNumber=74, createdTime=2013-02-19, rootId=0, userName=Eleven11, userId=e183245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a583152166d, moduleTitle=JAMA Pediatr:GLP-1受体激动剂抗青少年重度肥胖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a583152166d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

GLP-1受体激动剂

2020-05-29

Eleven11 (审核中...)

前往app查看评论内容

#GLP-1受体激动剂#

Diabetes Care：GLP-1受体激动剂可以作为青少年的成年发病型糖尿病(MODY)3型的替代治疗

2014-06-21

Eleven11 (审核中...)

前往app查看评论内容

#GLP-1受体激动剂#

Sanofi推迟GLP-1受体激动剂lixisenatide在FDA的申请

2013-09-15

Eleven11 (审核中...)

前往app查看评论内容

#GLP-1受体激动剂#

PUDF 2013：母义明-GLP-1受体激动剂，它们都一样吗？

2013-06-01

Eleven11 (审核中...)

前往app查看评论内容

#GLP-1受体激动剂#

JAMA Pediatr:GLP-1受体激动剂抗青少年重度肥胖

2013-02-19

科室
- - 订阅+
  - 更多科室
工具
服务